NPPA Fixes Retail Prices Of 22 Formulations

Mumbai, 4 May 2019: The national drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 22 formulations under Drugs Prices Control Order (DPCO), 2013 in related notification dated May 02, 2019.

Name of the formulations are mesalazine sachet, clotrimazole+ beclomethasone+ neomycin cream, telmisartan +cilnidipine+ chlorthalidone tablet, paracetamol +phenylephrine+caffeine (Anhydrous)+ diphenhydramine tablet, methylcobalamin+ pyridoxine + folic acid tablet, medoxomil + amlodipine + hydrochlorothiazide tablet (Trisertain 20), olmesartan medoxomil + amlodipine + hydrochlorothiazide tablet (Trisertain 40), Olmesartan Medoxomil + Amlodipine Tablet (Olsertain AM 40), Linezolid + Dextrose Injection (Zifi turbo 600), telmisartan + amlodipine + chlorthalidone tablet, clarithromycin tablet, esomeprazole tablet, amoxycillin tablet etc.

The manufacturers not complying with the ceiling price and notes specified herein above shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. 

Consequent to the issue of ceiling prices of such formulations as specified in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the said date of notification, stand(s) superseded, the NPPA in its notification said. Pharmabiz